| RERHX | STITX | RERHX / STITX | |
| Total Expense Ratio | 0.62 | 1.05 | 59% |
| Annual Report Gross Expense Ratio | 0.62 | 1.17 | 53% |
| Fund Existence | 11 years | 32 years | - |
| Gain YTD | 0.150 | -1.141 | -13% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 100000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 141B | 233M | 60,515% |
| Annual Yield % from dividends | 2.69 | 0.36 | 755% |
| Returns for 1 year | 2.92 | -1.23 | -238% |
| Returns for 3 years | 14.00 | -22.34 | -63% |
| Returns for 5 years | -6.17 | -33.75 | 18% |
| Returns for 10 years | 40.33 | -23.39 | -172% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HDGBX | 25.44 | N/A | N/A |
| Hartford Dividend and Growth HLS IB | |||
| VMGIX | 115.53 | N/A | N/A |
| Vanguard Morn Mid Cap Growth Index Inv | |||
| FRBRX | 212.19 | N/A | N/A |
| Franklin Biotechnology Discovery R6 | |||
| MUOCX | 32.55 | N/A | N/A |
| Morgan Stanley Instl US Core C | |||
| MKEFX | 20.53 | -0.42 | -2.00% |
| BlackRock International Select Eq K | |||